Rhythm Pharmaceuticals Inc (RYTM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2022 | 06-2022 | 03-2022 | 12-2021 | 09-2021 | |
| Sales | 4,284 | 9,066 | 1,498 | 1,817 | 1,028 |
| Cost of Goods | 497 | 378 | 230 | 236 | 222 |
| Gross Profit | 3,787 | 8,688 | 1,268 | 1,581 | 806 |
| Operating Expenses | 43,551 | 54,162 | 54,189 | 52,806 | 45,268 |
| Operating Income | -39,267 | -45,096 | -52,691 | -50,989 | -44,240 |
| Interest Expense | 2,144 | 46 | 0 | 0 | 0 |
| Other Income | 550 | 141 | -73 | 134 | 138 |
| Pre-tax Income | -40,861 | -45,001 | -52,764 | -50,855 | -44,102 |
| Income Tax | N/A | N/A | N/A | N/A | -8,995 |
| Net Income Continuous | -40,861 | -45,001 | -52,764 | -42,866 | -35,107 |
| Net Income | $-40,861 | $-45,001 | $-52,764 | $-42,866 | $-35,107 |
| EPS Basic Total Ops | -0.79 | -0.89 | -1.05 | -0.92 | -0.70 |
| EPS Basic Continuous Ops | -0.79 | -0.89 | -1.05 | -0.92 | -0.70 |
| EPS Diluted Total Ops | -0.79 | -0.89 | -1.05 | -0.90 | -0.70 |
| EPS Diluted Continuous Ops | -0.79 | -0.89 | -1.05 | -0.90 | -0.70 |
| EBITDA(a) | $-36,635 | $-44,658 | $-52,341 | $-50,664 | $-43,925 |